Lupin Limited has informed the Exchange regarding a press release dated December 15, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated December 15, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin Tablets.".